ArticleBlood cancer journal2011
The tyrosine kinase inhibitor dasatinib (SPRYCEL) inhibits chondrocyte activity and proliferation.
K Vandyke et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleBlood cancer journal2011
K Vandyke et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.